HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CLB

Core Laboratories Inc. (NYSE)

Energy — Oil & Gas Equipment & Services

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

None 3 analysts
$11.96
+$0.55 (+4.82%)
Target: $15.83 (32.4%)
Sign in to add CLB to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$533.34M
P/E Ratio (TTM)18.97
Forward P/E16.65
EPS (TTM)$0.61
Dividend Yield0.35%
Profit Margin5.53%
Revenue Growth-1.40%
ROE11.06%
Debt/Equity61.00
Recommendation None
Analyst Target$15.83
Analysts3
Indexes NYSE

Technical Indicators

RSI (14)29.8
Beta0.99
SMA 20-
SMA 40-
52-Week High$20.36
52-Week Low$9.72
50-Day Avg$13.62
200-Day Avg$15.45
Avg Volume814.6K
Volume738.9K

Performance Analysis

NEUTRAL

CLB presents a mixed picture with both positive and negative indicators.

~ Trading at 21% of its 52-week range.
+ RSI at 29.8 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 1.4% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $15.83 implies 32.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:03 UTC

Back to Screener Export Report